James Paul Scopa, Director at Adverum Biotechnologies, Inc. (ADVM), bought 10,000 shares at $13.75 ($138K) on 2020-02-14, disclosed to the SEC on 2020-02-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADVM | SELL | 2021-11-17 | $218K | — | Filing → |
| DICE | BUY | 2021-09-16 | $102K | — | Filing → |
| ADVM | BUY | 2019-05-06 | $134K | — | Filing → |